Actively Recruiting
Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women
Led by Instituto Médico Tecnológico SL · Updated on 2025-05-23
90
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
Sponsors
I
Instituto Médico Tecnológico SL
Lead Sponsor
R
RAPbarcelona
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to analyze the effectiveness of a telerehabilitation program with respect to a face-to-face physiotherapy protocol in relation to the improvement of sexual function, the reduction of pain and the improvement of the quality of life, in the treatment of menopausal women with dyspareunia.
CONDITIONS
Official Title
Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Age from 45 to 65 years
- Menopausal
- Suffer dyspareunia for 3 months of evolution
- Willing to complete study questionnaires and informed consent study
You will not qualify if you...
- Pacemaker or other types of electronic implant
- Thrombophlebitis
- Skin hypersensitivity or rejection of manual contact
- Active or previous treatment with chemotherapy or radiotherapy in the pelvic area
- Wounds or burns in the pelvic area
- Allergy to nickel and chromium
- Other pelvic floor physiotherapy treatments during the study intervention
- Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention
- Surgical intervention in the pelvic area in the last 3 months
- Fibromyalgia
- Oncological processes that affect the sacrum
- Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions)
- Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Myasthenia Gravis or spinal muscular atrophy)
- Myelopathy and Osteomyelitis
- Diseases that cause alterations of the central nervous system (traumatic or vascular spinal cord injury)
- Neurological or metabolic conditions that affect the ability to respond (Diabetes, Parkinson's disease, senile dementia, etc)
- Serious mental disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
RAPbarcelona
Barcelona, Spain, Spain, 08037
Actively Recruiting
Research Team
P
Paula Sanfeliu Rosell, MSc
CONTACT
I
Inés Ramírez García, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here